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Introduction:	 According	 to	 the	 latest	 statistical	 and	 epidemiological	
studies,	chronic	obstructive	pulmonary	disease	(COPD)	will	become	the	
fourth	leading	cause	of	death	in	2030	worldwide.	Scientists	are	studying	
on	methods	to	diagnose	COPD	in	the	patients	in	early	stages,	because	it	
is	 a	 curable	 and	 preventable	 disease	 in	 early	 stages.	 In	 this	 study,	
evidences	of	hyperinflation	on	chest	X-	ray	(CXR)	of	COPD	patients	were	
compared	with	pulmonary	function	test	(PFT)	finding.			
Materials	 and	 Methods:	 This	 cross-sectional	 study	 was	 done	 on	 100	
patients	 who	 were	 referred	 to	 the	 pulmonary	 clinic	 with	 symptoms	 of	
chronic	cough	and	dyspnea.	After	taking	history	and	performing	physical	
examination,	 demographic	 information,	 history	 of	 smoking	 and	 bakery	
and	 frequency	 of	 exacerbations	 were	 recorded.	 Standard	 spirometry	
was	 performed	 and	 the	 severity	 of	 COPD	 was	 determined	 by	 GOLD	
(Global	 initiative	 for	 chronic	 Obstructive	 Lung	 Disease)	 staging.	
Additionally,	 they	 underwent	 CXR	 examination	 (PA	 and	 lateral).	
Collected	data	were	analyzed	in	SPSS	ver.	18.		
Results:	In	this	study,	there	were	79	male	and	21	female.	The	patients,	
64%	 of	 whom	 were	 urban	 and	 36%	 were	 rural	 dwellers.	 There	 was	
significant	 correlation	 between	 forced	 expiratory	  low	 (FEF)	 50%	
predict	 with	 sterno-diaphragmatic	 angle	 and	 retro-sternal	 lucency	
(p=0.01,	 r=-0.26	 and	 p=0.01,	 r=-0.25	 respectively).	 Also	 there	 were	
significant	 correlations	 between	 the	 forced	 expiratory	 volume/forced	
vital	capacity	(FEV1/FVC)	with	retro-sternal	lucency	(p=0.006,	r=-0.27)	
and	FEV1%predict	with	sterno-diaphragmatic	angle	(p=0.002,	r=-0.31).	
Conclusion:	 The	 study	 showed	 some	 evidences	 of	 lung	 hyperinflation	
on	 CXR	 which	 significantly	 associated	 with	 PFT	 parameters.	 Sterno-
diaphragmatic	angle	and	retro-sternal	lucency	can	be	used	to	predict	the	
severity	of	airway	obstruction	in	patients	with	COPD,	although	the	CXR	
finding	cannot	be	substituted	for	PFT	and	CT	data.	
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Introduction	
Chronic	 Obstructive	 Pulmonary	 Disease	
(COPD)	 is	 a	 progressive	 disease	 with	 airflow	
limitation	 associated	 with	 abnormal	
	
inflammatory	 response	 of	 the	 lungs	 in	 response	
to	different	types	of	particles	and	gases.	It	is	one	
of	 the	 major	 causes	 of	 morbidity	 and	 mortality	
worldwide	 (1,	 2).	 	 Among	 COPD	 patients,	
smoking	 is	 considered	 as	 a	 major	 risk	 factor	
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associated	with	reduced	lung	function	(3).	COPD	
is	 associated	 with	 smoking	 in	 90%	 of	 cases	 (4).	
COPD	 also	 occurs	 in	 10-20%	 of	 smokers	 or	 ex-
smokers	(5). 
Airways	 obstruction	 during	 exhalation	
progressively	traps	air	and	causes	hyperinflation	
at	 rest	 and	 dynamic	 hyperinflation	 during	
activity.	 Hyperinflation,	 reduces	 inspiratory	
capacity	 and	 causes	 reduced	 functional	 residual	
capacity.	 These	 features	 can	 cause	 shortness	 of	
breath	 and	 reduced	 exercise	 capacity	 in	 COPD.	
Airflow	obstruction	in	COPD	is	best	measured	by	
spirometry	an	early	diagnostic	instrument	(6).	
Airways	 obstruction	 is	 an	 essential	 diagnostic	
criterion	 in	 COPD	 which	 is	 diagnosed	 by	
Spirometry.	 CT	 scan	 shows	 more	 details	 of	 the	
lung	 parenchyma	 in	 areas	 affected	 by	
emphysema	 (7).	 Chest	 X-ray	(CXR)	 has	a	 benefit	
in	 COPD	 patients	 and	 it	 should	 be	 performed	 to	
rule	out	other	causes	(8).	Characteristics	of	COPD	
in	 CXR	 are	 hyperinflation	 of	 the	 lungs	 with	
flattened	 diaphragm,	 the	 hyperleucent	 lungs,	
enlargement	of	the	pulmonary	arteries,	bula,	and	
areas	 of	 damaged	 pulmonary	 tissue	 that	 makes	
up	 the	 large	 air	 sacs	 (9).	 Although	 CXR	 is	 an	
insensitive	 and	 nonspecific	 procedure	 to	
diagnose	COPD	(10)	and	it	is	not	a	substitute	for	
spirometry,	 but	 it	 is	 inexpensiveness,	 accessibile	
and	 it	 can	 benefit	 physicians	 in	 evaluating	
patients	with	COPD.	
In	 a	 study	 by	 Miniati	 M	 et al,	 CXR	 scores	 on	
indices	of	airflow	obstruction	and	hyperinflation	
were	 comparable	 with	 those	 obtained	 using	
quantitative	and	qualitative	data	of	HRCT	(11).	A	
study	 by	 Ravindran	 C,	 and	 colleagues	 has	
concluded	 that	 the	 CXR	 can	 identify	 pulmonary	
artery	 hypertension	 in	 patients	 with	COPD.	 This	
study	 also	 reported	 a	 positive	 relationship	
between	 the	 diameter	 of	 the	 pulmonary	 artery	
and	 the	 hilar-thoracic	 ratio	 and	 other	 findings,	
such	 as	 smoking	 rates,	 symptoms	 and	 sign	
duration,	 and	 electrocardiographic	 (ECG)	
evidence	 of	 Right	 Ventricular	 Hypertrophy	
(RVH).	 There	 was	 also	 an	 inverse	 relationship	
with	 Forced	 Expiratory	 Volume	 in	 one	 second	
(FEV1)%predict	(12). 
Study	of	the	Komatsu	S,	on	diagnostic	radiology	
by	CXR,	chest	CT	and	MRI	is	shown	that;	CXR	was	
not	 a	 useful	 tool	 to	 detect	 early-stage	 COPD;	
however	 in	 the	 advanced	 stages	 of	 COPD	
following	 signs	 can	 be	 seen:	 pulmonary	 hypo-
vascularity,	 increasing	 radiolucency	 of	 the	 lung,	
depression	 and	 flattening	 of	 the	 diaphragm,	 and	
increasing	retro-sternal	lucency	(13).	
Another	 study	 by	 Shaker	 SB,	 et al	 on	 imaging	
findings	 in	 COPD	 especially	 in	 advanced	 disease	
reported	 a	 hyperinflation	 in	 the	 CXR	 (14).	 In	
contrast,	 other	 study	 by	 Maury	 G,	 et al	 found	
limited	 role	 for	 CXR	 in	 diagnosis	 of	 lung	
hyperinflation	while	pulmonary	function	test	was	
reported	as	the	gold	standard	(15).	
The	 purpose	 of	 this	 study	 was	 to	 evaluate	
patients	 with	 COPD	 with	 an	 easy	 and	 accessible	
way,	 and	 comparisons	 the	 evidence	 of	 lung	
hyperinflation	 on	 CXR	 with	 pulmonary	 function	
test	parameters.	
Materials	and	Methods	
This	study	is	a	cross-sectional	study.	A	total	of	
100	 patients	 referred	 to	 the	 lung	 clinic	 with	
symptoms	 of	 chronic	 productive	 cough	 and	
dyspnea	 with	 obstructive	 pattern	 without	
reversibility	 in	 Pulmonary	 Function	 Test	 (PFT)	
according	to	the	American	Thoracic	Society	were	
enrolled.	 The	 demographic	 data	 including	 age,	
gender,	 location,	 occupation,	 educational	 level,	
smoking	history,	bakery	period,	 the	frequency	of	
hospitalization	were	asked.		
The	 severity	 of	 airway	 obstruction	 was	
determined	according	 to	 the	Global	 initiative	 for	
chronic	 Obstructive	 Lung	 Disease	 (GOLD)	
guideline	 	 including:	 mild;	 FEV1/Forced	 Vital	
Capacity	 (FVC)	 <	 70%,	 	 FEV1>80%,	 moderate;		
FEV1/FVC	 <	 70%,	 50%	 ≤	 FEV1	 <	 80%,	 severe;	
FEV1/FVC	 <	 70%,	 30%	 ≤	 FEV1	 <	 50%,	 very	
severe;	FEV1/FVC	<	70%,		FEV1<	30%.			
The	 severity	 of	 dyspnea	 was	 determined	
according	 to	 the	 Modified	 Medical	 Research	
Council	 (MMRC)	 and	 graded	 between	 0	 and	 4	
based	 on	 the	 patient’s	 response.	 The	 subjects,	
quality	of	 life	was	assessed	by	COPD	assessment	
test	(CAT).	The	CAT	score	was	classified	into	four	
groups	 of	 impact	 levels:	 low	 (CAT	 score<10),	
medium	 (CAT	 score	 10-20),	 high(CAT	 score	 21-
30)	and	very	high(CAT	score	31-40).	Hemoglobin	
saturation	by	pulse	oximetry	(SPO2)	evaluated	in	
all	 patients.	 They	 underwent	 CXR	 examination	
(PA	 and	 lateral).	 	 In	 addition,	 information	 of	
hyperinflation	 in	 PA	 and	 lateral	 CXR	 were	
included	in	the	questionnaire	by	pulmonologist.		
Evidence of lung hyperinflation on CXR 
Standard	 CXR	 at	 full	 inspiration	 position	 was	
performed	 in	 all	 the	 patients.	 The	 seven	
parameters	were	evaluated	as	follows.	
Height	 of	 Right	 Lung:	 Lung	 apex	 along	 an	
imaginary	 line	 perpendicular	 to	 the	 upper	 inner	
to	the	margin	of	the	right	diaphragm	in	PA	chest	
radiography	measured	by	mm.	
Right	 Pulmonary	 Diameter:	 Maximum	
diameter	 of	 descending	 pulmonary	 artery	 in	 PA	
chest	radiography	measured	by	mm.	
Retro-Sternal	 Lucency:	 Maximum	 retro-
sternal	 lucency	 in	 Lewis	 angle	 in	 PA	 chest	
radiography	measured	by	mm.	
Right	 Diaphragmatic	 Height:	 Distance	
between	 an	 imaginary	 line	 connecting	 internal	
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and	 external	 sides	 and	 peak	 of	 right	 diaphragm	
measured	in	mm.	in	the	PA	chest	radiography.	
Sterno-Diaphragmatic	 Angle:	 The	 angle	
between	 the	 sternum	 bone	and	 right	diaphragm	
in	lateral	chest	radiography.	
Cardio-Thoracic	Ratio:	The	ratio	of	maximum	
length	of	heart	to	maximum	thoracic	length	in	PA	
chest	radiography.	
Mediastinal-Thorax	 Ratio:	 The	 maximum	
length	 of	 the	 mediastinum	 in	 lower	 edge	 of	 the	
aortic	arch	 to	 the	 maximum	 thorax	 length	 on	 an	
imaginary	line	in	PA	chest	radiography.	
Statistical analysis of the data 
The	data	were	analyzed	using	SPSS	version	18.	
Descriptive	 and	 analytical	 methods	 for	 data	
classification,	and	the	average	frequency	of	use	of	
descriptive	statistics	in	the	form	of	diagrams	and	
tables	 were	 set	 up.	 To	 examine	 the	 differences	
between	 groups,	 ANOVA	 and	 Independent-
Samples	 T	 Test	 and	 Parametric	 (Pearson)	 was	
used	 to	 determine	 the	 correlation	 between	
variables.	 Less	 than	 0.05	 was	 considered	
significant	 in	 all	 tests.	 Written	 consent	 was	
obtained	from	all	the	patients	in	admission.	This	
study	 was	 approved	 by	 the	 Ethics	 Committee	 of	
the	Ardabil	University	of	Medical	Sciences.	
Results	
The	study	included	100	patients	referred	to	the	
pulmonary	clinic	with	symptoms	of	dyspnea	and	
chronic	 productive	 cough	 in	 years	 2012-2013.	
The	 mean	 age	 of	 the	 patients	 was	 65.16±11.27	
years	 of	 whom	 79%	 male	 and	 21%	 female.	 The	
majority	 of	 the	 patients,	 64%	 were	 urban	
dweller.	Eighty-one	percent	of	the	patients	had	a	
history	 of	 smoking	 and	 19%	 bakery	 workers.	
Average	 CAT	 score	 was	 24.78±6.45,	 and	 50%	 of	
the	patients	were	in	the	severe	group.	Eighty-one	
percent	 of	 patients	 did	 not	 mention	 history	 of	
exacerbation	during	the	last	year.	The	mean	SPO2	
was	 92.4±64.41.	 Demographic	 and	 Paraclinical	
findings	of	the	patients	are	listed	in	Table	1.	
A	 weak	 inverse	 relationship	 between	 Forced	
Expiratory	 Flow	 (FEF)	 50%	 with	 retro-sternal	
lucency	 and	 sterno-diaphragmatic	 was	 angle	
observed	 (r	 =	 -0.25,	 P	 =	 0.01,	 and	 r	 =	 -0.26,	 P	 =	
0.01	 respectively).	 A	 weak	 but	 direct	 statistical	
relationship	 was	 also	 observed	 between	 the	
height	of	the	right	diaphragm	with	FEF	50%	(r	=	
+0.22,	P	=	0.02)	
A	 weak	 and	 inverse	 association	 was	 observed	
between	 FEV1%	 predict	 and	 sterno-
diaphragmatic	 angel	 (r	 =	 -0.31,	 P	 =	 0.002).	 In	
addition,	 a	 weak	 statistical	 relationship	 was	
found	 between	 retro-sternal	 lucency	 and	
FVC/FEV1	 (r	 =	 -0.27,	 P	 =	 0.006).	 The	 results	 of	
the	 CXR	 evidence	 and	 its	 relationship	 with	 PFT	
findings	are	listed	in	Table	2.	
Table1.	Demographic	characteristics	and	Para	clinical	results.	
Mean±SD 
Subjects	
(Number) 
 
65.16±11.27	100 Age(years) 
 79/21 Sex(M/F) 
 64/36	Residency(Urban/Rural)	
26.71±16.11 81(79/3) Smoking	history	(M/F) 
4.84±10.81	19(1/18)	Baking	History	
57.82±10.82	100	FEV1/FVC%	
49.05±16.45 100 FEV1%	predict 
63.79±18.19	100	FVC%	predict	
19.82±12.50	100	FEF50%	predict	
1.72±0.77 100 MMRC(dyspnea	scale) 
92.46±4.41 100 SPO2% 
24.78±6.45	100	CAT	score	
		Exacerbation	Rate	
	81	No	exacerbation	
	15	One	exacerbation	
 4 Two	exacerbation 
Information	 about	 the	 number	 of	 patients	
according	to	the	GOLD	classification,	the	intensity	
of	 dyspnea	 using	 MMRC	 scale	 and	 impact	 of	 the	
disease	 on	 quality	 of	 life	 assessed	 by	 CAT	 tests	
are	listed	in	Table	3.	
The	 results	 of	 CXR	 of	 patients	 are	 listed	 in	
Table	4.	And	the	relationship	between	the	results	
of	 the	 CXR	 with	 MMRC,	 GOLD,	 CAT	 is	 listed	 in	
Table	5.		
Table	2.	Correlation	between	evidences	of	CXR	hyperinflation	and	PFT	parameters	
FEF50%predict	FEV1%predict	FEV1/FVC	
Air	Trapping	Evidence	on	CXR	
Correlation	P	Value	Correlation	P	Value	Correlation	P	Value	
-0.17	0.08 -0.17	0.10 -0.12	0.23 Height	of	Right	Lung	
-0.08	0.41 -0.16	0.11 -0.08	0.45 Right	Pulmonary	Diameter 
-0.25	0.01 -0.18	0.08 -0.27	0.006 Retro-Sternal	Lucency	
+0.22	0.02 +0.16	0.12 +0.13	0.19 Right	Diaphragmatic	Hieght 
-0.26	0.01 -0.31	0.002 -0.18	0.08 Sterno-Diaphragmatic	Angle	
+0.007	0.94 -0.03	0.73 +0.14	0.17 Cardio-Thoracic	Ratio	%	
-0.11	0.26 -0.15	0.15 +0.06	0.55 Mediastinal-Thorax	Ratio	% 
	
Table	3.	Subjects	distribution	by	GOLD,	MMRC,	CAT.	
CAT	Impact	Level	MMRC(dyspnea	scale)	Gold	Classification		
0	1	0 Normal	
3	43	3	Mild	
22	40	48	Moderate	
50	15	42	Severe	
25 1 7	Very	severe 
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Table	4.	CXR	findings. 
Mean±SD Subjects(Number)  
270.73±32.85	100 Height	of	Right	Lung	*	
13.15±2.79 100 Right	Pulmonary	Diameter	* 
66.28±17.83 100	Retro-Sternal	Lucency	*	
24.79±6.37 100 Right	Diaphragmatic	Hieght	* 
64.74±13.79	100	Sterno-Diphragmatic	Angle	(Degree)	
0.48±0.05	100	Cardio-Thoracic	Ratio	%	
0.25±0.04 100 Mediastinal-Thorax	Ratio	% 
*	Values	are	presented	as	millimeter	
Table	5.	Association	between	CXR	and	parameters	of	MMRC	and	CAT	Group. 
GOLD	Classification	Impact	Level	(CAT)	MMRC	Air	Trapping	Evidence	
on	CXR	 P	Value	P	Value	P	Value	
0.06 0.71 0.53 Height	of	Right	Lung	
0.27 0.84 0.14 Right	Pulmonary	Diameter 
0.75 0.55 0.34 Retro-Sternal	Lucency	
0.58 0.88 0.75 Right	Diaphragmatic	Hieght 
0.01 0.11 0.65 Sterno-Diaphragmatic	Angle	
0.10 0.67 0.45 Cardio-Thoracic	Ratio	%	
0.16 0.29 0.19 Mediastinal-Thorax	Ratio	% 
	
These	 findings	 did	not	support	 the	 correlation	
between	 the	 CXR	 parameters	 and	 intensity	 in	
dyspnea	and	patients'	quality	of	life,	however	our	
findings	 confirm	 previous	 findings	 on	 the	
association	 between	 severity	 of	 the	 disease	
according	to	The	GOLD	classification	and	sterno-
diaphragmatic	angle	(p	=	0.01).	
Statistical	 correlation	 was	 observed	 between	
the	SPO2	with	right	descending	pulmonary	artery	
diameter	 and	 sterno-diaphragmatic	 angle	 (r	 =	 -
0.21,	P	=	0.03,	and	r	=	-0.22,	P	=	0.02	respectively)	
(Table	6).	
Table	6.	Association	between	SPO2	and	CXR. 
SPO2	Air	Trapping	Evidence	on	
CXR	 Correlation	P	Value	
-0.24	0.01 Height	of	Right	Lung	
-0.21	0.03 Right	Pulmonary	Diameter 
-0.14	0.15 Retro-Sternal	Lucency	
-0.13	0.19 Right	Diaphragmatic	Hieght 
-0.22	0.02 Sterno-Diaphragmatic	Angle	
+0.04	0.66 Cardio-Thoracic	Ratio	%	
+0.01	0.91 Mediastinal-Thorax	Ratio	% 
Discussion	 	
This	 study	 shows	 a	 weak	 correlation	 between	
FEV1	and	sterno-diaphragmatic	angle	(Figure	1).	
There	 is	 also	 a	 weak	 correlation	 between	
FEV1/FVC	and	retro-sternal	lucency.	A	statistical	
association	 was	 shown	 between	 FEF	 50%	 with	
retro-sternal	 lucency	 and	 right	 diaphragmatic	
height.	
COPD	 patients	 have	 air	 trapping	 in	 chest.	
Diaphragm	 widening	 is	 the	 most	 important	
measure	 of	 air	 trapping	 and	 it	 may	 be	 seen	 as	
increasing	sterno-diaphragmatic	angle	and	retro-
sternal	 lucency	 in	 CXR.	 Komatsu	 S,	 did	 not	 also	
find	 CXR	 as	 accurate	 diagnostic	 method	 to	
evaluate	 early-stage	 COPD,	 but	 CXR	 shows	 an	
increased	 retro-sternal	 lucency	 and	
diaphragmatic	 widening	 in	 the	 advanced	 stages	
of	 the	 disease	 (13).	 An	 association	 was	 also	
reported	between	the	height	of	the	diaphragm	in	
CXR	and	 FEV1	by	Petrukhin	(16).	 In	 the	 present	
study	 retro-sternal	 lucency	 had	 a	 significant	
inverse	 correlation	 with	 FEV1/FVC	 which	 is	 in	
accordance	 with	 reported	 findings	 of	 Siafakas	N,	
(17). 
	
	
Figure	 1.	 Correlation	 between	 FEV1	 with	 sterno-
diaphragmatic	angle.	
Although	low	sensitivity	and	specificity	are	the	
limitations	 of	 CXR	 (especially	 in	 mild	
emphysema),	 availability	 is	 the	 main	 benefit	 of	
this	 method	 in	 the	 evaluation	 of	 lung	 disease	
(18).	Most	authors	recommend	to	perform	CXR	in	
patients	 with	 suspected	 pulmonary	 disease	
should	 be	 performed.	 CXR	 is	 often	 the	 first	
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imaging	 assessment	 of	 lung	 diseases	 including	
COPD	 to	 rule	 out	 other	 causes	 in	 patients	 with	
cough	and	dyspnea.	CXR	is	also	used	to	diagnose	
those	factors	flaring	up	COPD	(19).	
Imaging	 has	 limited	 value	 in	 the	 evaluation	 of	
patients	with	COPD	(15)	and	CT	scan	findings	in	
the	 evaluation	 of	 asymptomatic	 smokers	 are	
better	 than	 CXR	 (8),	 in	 fact	 the	 results	 of	 CXR	
findings	 was	 comparable	 with	 lung	CT	 scan	 in	 a	
study	(11).	The	availability	of	CXR	made	it	as	the	
first	 diagnostic	 method	 in	 the	 evaluation	 of	
emphysema.	 The	 relationship	 between	 PFT	
parameters	 and	 severity	 of	 airflow	 obstruction	
and	 radiographic	 findings	 of	 CXR	 for	 pulmonary	
physicians	is	of	great	importance.	The	majority	of	
studies	have	shown	that	in	the	advanced	stage	of	
disease,	 CXR	 is	 useful	 for	 evaluating	
hyperinflation	 (10,	 14)	 therefore	 can	 be	 used	 in	
the	assessment	of	lung	hyperinflation.	
The	CXR	is	also	used	to	assess	the	magnitude	of	
cardiomegaly	 secondary	 to	 pulmonary	 disease	
and	 pulmonary	artery	hypertension	 (12).	 In	 this	
study	the	correlation	between	the	magnitudes	of	
cardiomegaly	(Corpulmonal),	the	diameter	of	the	
right	 descending	 pulmonary	 artery	 (as	 an	 index	
of	 pulmonary	hypertension)	 with	 the	 severity	of	
airway	 obstruction	 and	 values	 of	 FEV1	 was	
checked	 and	 found	 no	 significant	 relationship,	
although	 a	 weak	 statistical	 association	 was	
observed	between	SPO2	and	the	right	descending	
pulmonary	artery	diameter.	(Figure	2)	(r	=	-0.21,	
P	=	0.03).	
An	 association	 was	 reported	 between	 the	 size	
of	descending	pulmonary	artery	and	hillar-thorax	
ratio	 (C-Ravindran	 et al).	 There	 was	 also	
observed	 an	association	between	the	 pulmonary	
artery	 diameter	 and	 smoking	 status,	 duration	 of	
symptoms	 and	 evidence	 of	 RVH	 in	 ECG	 (12).	 In		
	
Figure	 2.	 Correlation	 between	 SPO2	 with	 right	 descending	
pulmonary	diameter.	
our	 study,	 an	 association	 was	 not	 observed	
between	 the	 pulmonary	 artery	 and	 hilar-thorax	
ratio.	This	result	was	found	because	high	number	
of	 the	 samples	 were	 in	 mild	 or	 moderate	 stages	
(based	on	the	GOLD	classification).	Although	this	
finding	is	indicative	of	the	fact	that	other	factors	
including	 alveolar	 hypoxia,	 systemic	
inflammation,	 abnormal	 pulmonary	 vascular	
beds	and	endothelial	cell	dysfunction	play	a	role	
in	the	occurrence	of	pulmonary	hypertension	and	
cor-pulmonale	instead	of	airflow	obstruction.	
In	 the	 present	 study,	 there	 was	 significant	
association	between	smoking	status	and	evidence	
of	 hyperinflation	 on	 CXR	 (i.e.	 correlated	 with	
right	lung	height,	sterno-diaphragmatic	angle	and	
retro-sternal	 lucency,	 and	an	 inverse	 association	
with	hilar-thoracic	ratio).	This	indicates	the	effect	
of	smoking	as	an	independent	risk	factor	for	the	
disease	and	the	severity	of	airway	obstruction.	
Our	 findings	 did	 not	 support	 result	 of	 a	 study	
by	Watz	H,	et al,	 in	which	an	inverse	association	
was	 found	 between	 Cardio-thoracic	 ratio	 and	
GOLD	 Stage	 (20).	 	 In	 our	 study	 there	 was	 a	
significant	 association	 between	 the	 GOLD	 Stage	
and	 sterno-diaphragmatic	 angle.	 The	 current	
finding	 may	 also	 indicate	 association	 of	
diaphragatic	 widening	 in	 COPD	 patients	 by	
severity	of	airway	obstruction.	
Bellemare	J-F.	reported	an	association	between	
diaphragmatic	 height	 and	 the	 age	 of	 COPD	
patients,	 but	 our	 findings	 did	 not	 support	 their	
findings.	 Diaphragmatic	 height	 which	 indicates	
pulmonary	hyperinflation	increases	by	age	and	it	
occurs	 mostly	 in	 ages	 above	 65	 years	 old.	
However,	in	our	study,	probably	due	to	the	lower	
age	of	the	patients,	the	height	of	diaphragm	is	not	
significantly	 associated	 with	 age.	 In	 present	
study,	 age	 only	 was	 associated	 with	 cardio-
thoracic	 ratio.	 There	 was	 not	 any	 other	
association	 between	 age	 and	 other	 evidence	 of	
CXR	 hyperinflation	 (21).	 This	 shows	 that	 the	
severity	of	disease	is	not	related	only	to	the	age	of	
the	patient	and	smoking	is	the	main	risk	factor	of	
the	disease.	
Our	 study	 had	 some	 limitations.	 The	 first	
limitation	 was	 the	 relatively	 small	 sample	 size,	
that	 may	 be	 altered	 the	 study	 finding.	 Secondly,	
some	 subjects	 had	 not	 full	 inspiration	 in	 CXR	
which	 alter	 the	 results,	 although	 researchers	
tried	 to	 minimize	 the	 effect	 of	 confounding	 by	
patients	learning.	
Conclusion	
This	 study	 showed	 some	 evidences	 of	 lung	
hyperinflation	on	CXR	are	significantly	associated	
with	 PFT	 parameters.	 In	 patients	 with	 COPD,	
some	 parameters	 in	 CXR	 (sterno-diaphragmatic	
angel	 and	 retro-sternal	 lucency)	 can	 be	 used	 to	
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predict	 the	 severity	 of	 airway	 obstruction.	
Although	CXR	is	not	the	optimal	technique	for	the	
diagnosis,	 it	 can	be	utilized	 in	 the	 assessment	 of	
COPD	 severity	 and	 to	 rule	 out	 other	 causes	 in	
patients	 with	 pulmonary	 symptoms	 (dyspnea,	
cough,	and	sputum).	
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